Invitrocue logo

Invitrocue

Invitrocue Pte Ltd. | Transforming Bioanalytics

32 employees · est. 2012 · United States

VS
Trapelo logo

Trapelo

How can we resolve the complexities of using precision medicine for cancer care? Trapelo knows.

12 employees · est. 2009 · Burlington, United States

Trapelo is the older company (2012 vs 2009).

Side-by-Side Comparison

Invitrocue Trapelo
Founded
2012 2009 older
Headquarters
United States Burlington, United States
Employees
32 12
Industry
Biotechnology, Health Care, Manufacturing Health Care, IT
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet $7.66M
Funding Rounds
Not tracked yet 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Life Sciences, 3D Cell-based Models, Patient-Derived Organoids, In Vitro Drug Screening, Personalized Medicine, Precision Oncology, Cancer Research, Pharmacology, Clinical Decision Support, Contract Research Organization, Pharmacology Services, Safety Assessment, Healthcare Innovation Precision Medicine, Oncology, Cancer Care, Decision Support Platform, Molecular Testing, Real-time Information, Evidence-based Care, Health IT, Clinical Evidence, Genomic Changes, Targeted Therapies, Collaborative Network, Reimbursement Assurance, Patient-centered Care
Website
invitrocue.com trapelohealth.com
Invitrocue logo

About Invitrocue

Invitrocue is an innovative life sciences company that specializes in developing ground-breaking 3D cell-based models such as Patient-Derived Organoids (PDOs) from all solid cancers. The company's Onco-PDO technology enables patient-derived cancer cells to be cultured in laboratories for testing aga...

Trapelo logo

About Trapelo

Trapelo is a healthcare and IT startup founded in 2009 in the United States. The company offers a pioneering technology platform, Trapelo™, dedicated to fostering precision medicine in cancer care. By aligning the interests of oncologists, molecular labs, and payers, Trapelo aims to provide real-tim...

We will tell you when either one moves

BounceWatch watches Invitrocue and Trapelo for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Invitrocue and Trapelo — by email.

Frequently Asked Questions

Invitrocue — Invitrocue Pte Ltd. | Transforming Bioanalytics. Trapelo — How can we resolve the complexities of using precision medicine for cancer care? Trapelo knows. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Invitrocue has raised undisclosed funding while Trapelo has raised $7.66M.
Invitrocue and Trapelo operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Invitrocue with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Invitrocue on 12 Sep 2024, and Trapelo on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy